Results for "HDA Factbook"
Healthcare Distributors Are Making a Difference in Local Communities
Long before the COVID-19 pandemic, HDA healthcare distributors recognized the vital role that philanthropy plays in building healthier communities — and the industry’s responsibility in leading these efforts.
Reimagining the Pharmaceutical Supply Chain
HDA's President and CEO Chip Davis participated in a panel discussion at The Milken Institute’s 2022 Future of Health Summit entitled, “Reimagining the Pharmaceutical Supply Chain in the United States,” discussing the fundamental resilience of the pharmaceutical supply chain, while exploring the gaps and deepened growing health inequities unearthed by recent public health events.
Five Things to Know: Pharmaceutical Distributors and Vaccine Distribution
The successful development of COVID-19 vaccines will mark a groundbreaking step in our fight against the pandemic. However, the massive demand for approved vaccines and therapies as they come to market will require extensive coordination across the pharmaceutical supply chain and with the public sector.
How 2023 Will Shape the Future of Healthcare Supply Chain Resilience
Recently, HDA surveyed our distributor members and other subject matter experts to gain insights into current data and information sharing within the healthcare sector, and these findings have been distilled in our latest report, Healthcare Supply Chain Resilience and Data Illumination. This report documents the role of public-private partnerships in the COVID-19 response, while outlining some challenges and actionable recommendations to maintain long-standing data-sharing agreements. Read to learn more about these topics and the report's findings.